Literature DB >> 21512667

Brain metastases with exceptional features from papillary thyroid carcinoma: report of three cases.

Yan-Hong Xu1, Hong-Jun Song, Zhong-Ling Qiu, Quan-Yong Luo.   

Abstract

We present three papillary thyroid carcinoma PTC patients with brain metastases who are unusual in many aspects. The first case is a unique 3mm papillary thyroid microcarcinoma (PTMC) patient with metastases to the cerebrum and lung. The solitary cerebral lesion was identified by iodine-131 whole- body scan ((131)I-WBS) and (131)I single photon emission tomography/computed tomography (SPET/CT). Almost complete response achieved after radiosurgery. The second case is a unique PTC patient with coexistent (131)I-negative cerebrum, adrenal gland and ilium metastases, which were identified by (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT) and magnetic resonance imaging (MRI). Partial response achieved after radiosurgery. The third case is a patient with an incident solitary cystic cerebellar mass as a primary presentation of follicular variant of PTC and absent other distant metastases. In conclusion, widespread metastases from small PTMC may occur. Concomitant brain and adrenal metastases may occur in a same PTC patient. Brain metastasis may present as a cystic lesion.

Entities:  

Mesh:

Year:  2011        PMID: 21512667

Source DB:  PubMed          Journal:  Hell J Nucl Med        ISSN: 1790-5427            Impact factor:   1.102


  9 in total

1.  Adrenal metastasis from differentiated thyroid carcinoma documented on post-therapy (131)I scan: A case based discussion.

Authors:  Rohit Ranade; Pradeep Thapa; Sandip Basu
Journal:  World J Radiol       Date:  2014-03-28

2.  Brain metastases from papillary thyroid carcinomas.

Authors:  Farnaz C Tahmasebi; Peter Farmer; Suzanne Z Powell; Kenneth D Aldape; Gregory N Fuller; Shital Patel; Peter Hollis; David Chalif; Mark B Eisenberg; Jian Yi Li
Journal:  Virchows Arch       Date:  2013-03-27       Impact factor: 4.064

3.  Associations of BRAF V600E, clinical pathology and imaging factors with the recurrence rate of papillary thyroid microcarcinoma.

Authors:  Kun Huang; Ningning Gao; Donglin Bian; Qixi Zhai; Puxu Yang; Yunfei Zhang
Journal:  Exp Ther Med       Date:  2020-10-22       Impact factor: 2.447

4.  Papillary thyroid microcarcinoma presenting as a metastasis to the brain.

Authors:  M Shawky; I Proctor; T Kurzawinski; T Abdel-Aziz
Journal:  Ann R Coll Surg Engl       Date:  2020-04-01       Impact factor: 1.891

5.  Cerebellum as Initial Site of Distant Metastasis from Papillary Carcinoma of Thyroid: Review of Three Cases.

Authors:  Mutahir A Tunio; Mushabbab Al Asiri; Khalid Hussain Al-Qahtani; Wafa AlShakweer
Journal:  Case Rep Neurol Med       Date:  2015-05-06

6.  Correlation between Ultrasonographic Appearance of Papillary Thyroid Microcarcinoma and BRAF V600E Mutation.

Authors:  Songnian Liang; Kun Huang
Journal:  J Oncol       Date:  2022-03-21       Impact factor: 4.375

7.  Evaluation of surgical risk and prognosis between thyroid nodules of size <1 and ≥1 cm.

Authors:  Jia-Min Ma; Lin-Feng Wu; Ji-Sheng Hu; Zong-Wen Zhu; Guang-Zhou Li; Guo-Qing Li; Bei Sun; Gang Wang
Journal:  Gland Surg       Date:  2019-12

8.  Papillary thyroid microcarcinoma with lung metastases: a case report and review of the literature.

Authors:  Tadafumi Shimizu; Takaaki Oba; Tatsunori Chino; Ai Soma; Mayu Ono; Tokiko Ito; Toshiharu Kanai; Kazuma Maeno; Yoshinori Sato; Takeshi Uehara; Ken-Ichi Ito
Journal:  Thyroid Res       Date:  2021-06-11

9.  Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.

Authors:  Tada Kunavisarut; Ipshita Kak; Christina Macmillan; Ranju Ralhan; Paul G Walfish
Journal:  BMC Cancer       Date:  2012-11-15       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.